annual current assets:
$745.03M+$12.85M(+1.75%)Summary
- As of today (July 7, 2025), RARE annual total current assets is $745.03 million, with the most recent change of +$12.85 million (+1.75%) on December 31, 2024.
- During the last 3 years, RARE annual current assets has fallen by -$111.58 million (-13.03%).
- RARE annual current assets is now -42.48% below its all-time high of $1.30 billion, reached on December 31, 2020.
Performance
RARE Current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current assets:
$699.15M-$117.97M(-14.44%)Summary
- As of today (July 7, 2025), RARE quarterly total current assets is $699.15 million, with the most recent change of -$117.97 million (-14.44%) on March 31, 2025.
- Over the past year, RARE quarterly current assets has increased by +$103.19 million (+17.31%).
- RARE quarterly current assets is now -46.02% below its all-time high of $1.30 billion, reached on December 31, 2020.
Performance
RARE quarterly current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
RARE Current assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.8% | +17.3% |
| 3 y3 years | -13.0% | -1.2% |
| 5 y5 years | -12.4% | -21.8% |
RARE Current assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.7% | +1.8% | -31.0% | +17.3% |
| 5 y | 5-year | -42.5% | +1.8% | -46.0% | +17.3% |
| alltime | all time | -42.5% | +6702.1% | -46.0% | +1166.0% |
RARE Current assets History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $699.15M(-14.4%) |
| Dec 2024 | $686.33M(-9.6%) | $817.12M(+2.2%) |
| Sep 2024 | - | $799.61M(-17.1%) |
| Jun 2024 | - | $964.64M(+61.9%) |
| Mar 2024 | - | $595.97M(-18.6%) |
| Dec 2023 | $758.83M(+14.7%) | $732.18M(+22.2%) |
| Sep 2023 | - | $599.19M(-14.7%) |
| Jun 2023 | - | $702.14M(-8.4%) |
| Mar 2023 | - | $766.34M(-13.3%) |
| Dec 2022 | $661.54M(-0.6%) | $883.90M(-12.7%) |
| Sep 2022 | - | $1.01B(+49.2%) |
| Jun 2022 | - | $678.54M(-4.1%) |
| Mar 2022 | - | $707.52M(-17.4%) |
| Dec 2021 | $665.79M(+43.4%) | $856.60M(+1.1%) |
| Sep 2021 | - | $846.88M(-10.8%) |
| Jun 2021 | - | $949.49M(-11.3%) |
| Mar 2021 | - | $1.07B(-17.3%) |
| Dec 2020 | $464.25M(+63.2%) | $1.30B(+48.5%) |
| Sep 2020 | - | $872.00M(-3.8%) |
| Jun 2020 | - | $906.04M(+1.3%) |
| Mar 2020 | - | $894.32M(+5.1%) |
| Dec 2019 | $284.48M | $851.02M(+38.7%) |
| Sep 2019 | - | $613.49M(-12.3%) |
| Jun 2019 | - | $699.43M(-11.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $786.89M(+50.6%) |
| Dec 2018 | $197.19M(-10.8%) | $522.37M(-7.9%) |
| Sep 2018 | - | $567.48M(-6.2%) |
| Jun 2018 | - | $604.74M(+4.0%) |
| Mar 2018 | - | $581.58M(+115.7%) |
| Dec 2017 | $221.17M(+59.2%) | $269.58M(-31.0%) |
| Sep 2017 | - | $390.90M(-6.9%) |
| Jun 2017 | - | $419.79M(-5.6%) |
| Mar 2017 | - | $444.69M(+10.7%) |
| Dec 2016 | $138.93M(+27.0%) | $401.69M(-3.6%) |
| Sep 2016 | - | $416.79M(+1.4%) |
| Jun 2016 | - | $411.08M(-4.5%) |
| Mar 2016 | - | $430.23M(-4.4%) |
| Dec 2015 | $109.36M(+2303.0%) | $450.21M(-2.3%) |
| Sep 2015 | - | $460.71M(+36.9%) |
| Jun 2015 | - | $336.53M(-4.0%) |
| Mar 2015 | - | $350.51M(+81.2%) |
| Dec 2014 | $4.55M(+2.9%) | $193.42M(-6.4%) |
| Sep 2014 | - | $206.74M(+30.7%) |
| Jun 2014 | - | $158.22M(-6.7%) |
| Mar 2014 | - | $169.64M(+207.2%) |
| Dec 2013 | $4.42M(+136.5%) | $55.23M(-17.2%) |
| Sep 2013 | - | $66.67M(-22.9%) |
| Dec 2012 | $1.87M(+59.1%) | $86.44M |
| Dec 2011 | $1.18M | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual total current assets?
- What is the all time high annual current assets for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual current assets year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly total current assets?
- What is the all time high quarterly current assets for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly current assets year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual total current assets?
The current annual current assets of RARE is $745.03M
What is the all time high annual current assets for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual total current assets is $1.30B
What is Ultragenyx Pharmaceutical Inc. annual current assets year-on-year change?
Over the past year, RARE annual total current assets has changed by +$12.85M (+1.75%)
What is Ultragenyx Pharmaceutical Inc. quarterly total current assets?
The current quarterly current assets of RARE is $699.15M
What is the all time high quarterly current assets for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly total current assets is $1.30B
What is Ultragenyx Pharmaceutical Inc. quarterly current assets year-on-year change?
Over the past year, RARE quarterly total current assets has changed by +$103.19M (+17.31%)